Cytek Biosciences Inc (CTKB)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Receivables turnover		3.45	3.31	3.54	3.85	3.36	3.91	4.05	4.58
DSO	days	105.76	110.43	103.15	94.73	108.73	93.28	90.18	79.71

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.45
= 105.76

Days Sales Outstanding (DSO) is a financial ratio that measures how long it takes for a company to collect its accounts receivable. A lower DSO indicates that the company is collecting its receivables more quickly.

Looking at the trend in Cytek Biosciences Inc's DSO over the past several quarters, we can observe some fluctuations. The DSO was 105.76 days at the end of December 2023, which was higher compared to the previous quarter at 110.43 days. This suggests that the company took longer to collect its accounts receivable in the most recent quarter.

Furthermore, comparing the DSO at the end of December 2023 to the same period in the previous year, where the DSO was 108.73 days, we see a slight improvement in the company's collection efficiency.

It is important for Cytek Biosciences Inc to closely monitor and manage its DSO to ensure timely collection of receivables, as a high DSO can indicate potential liquidity issues or inefficiencies in the accounts receivable process. By analyzing the DSO trend over time, the company can identify areas for improvement and implement strategies to enhance cash flow management.